Zogenix Opens Photo Contest to Benefit Advocacy Groups

Zogenix Opens Photo Contest to Benefit Advocacy Groups

296252

Zogenix Opens Photo Contest to Benefit Advocacy Groups

The biopharmaceutical company Zogenix is introducing a Dravet syndrome community photo-sharing campaign and contest to benefit the Dravet Syndrome Foundation and the Epilepsy Foundation. U.S. families of Dravet patients whose seizures are treated with Fintepla (fenfluramine) — an add-on therapy developed by Zogenix — may enter the Fintepla Photo Diary contest by June 9. The company is asking that patients, or their caregivers, share photos of their everyday life, raising up to $50,000 for the…

You must be logged in to read/download the full post.